FOCINVEZ

Product NDC
82449-231
11-digit product format
824490231
Labeler code
82449
Product ID
82449-231_4e50b25f-abb3-dcb2-e063-6394a90a2517
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
FOSAPREPITANT DIMEGLUMINE
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Steriscience Specialties Private Limited
Application
NDA216686
Marketing category
NDA
Marketing start
2024-06-26
Substance
FOSAPREPITANT DIMEGLUMINE
Active strength
150 mg/50mL
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N216686-001FOCINVEZFOSAPREPITANT DIMEGLUMINEEQ 150MG BASE/50ML (EQ 3MG BASE/ML)SOLUTION / INTRAVENOUSRLD, RS2023-08-22

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N216686-001110652652039-01-11Drug product2023-09-13
N216686-001120425042039-01-11Drug product2024-08-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N216686-001FOCINVEZEQ 150MG BASE/50ML (EQ 3MG BASE/ML)SOLUTION / INTRAVENOUSRLD, RS2023-08-22a50c72e98297…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-08-01 22:54:322026-06N216686-001110652652039-01-11Drug product2023-09-13a50c72e98297…
2026-08-01 22:54:322026-06N216686-001120425042039-01-11Drug product2024-08-12a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FOCINVEZFOSAPREPITANT DIMEGLUMINEAmneal Pharmaceuticals LLC7afe33d8-5416-465a-b98b-f4eedc327a942026-04-17Warnings, Adverse reactionsExact identifier
application applno (NDA): 216686
application number: NDA216686
FOCINVEZFOSAPREPITANT DIMEGLUMINESteriscience Specialties Private Limited18a60093-cec8-1b8c-e063-6394a90a89022026-03-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 216686
application number: NDA216686
ndc (product): 82449-231

Additional Listing Data#

Finished product
Yes
Brand name base
FOCINVEZ
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FOSAPREPITANT DIMEGLUMINE150 mg/50mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
D35FM8T64XInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2664065Internal RxNorm lookup
2664071Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
18a60093-cec8-1b8c-e063-6394a90a8902Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
2abc3e32-ae1f-4dec-be1c-0c39ac95b38eProduct name720240514
5d352eda-d4de-4572-9a3f-32d6fd204f9aProduct name120230911
3a5d67cc-4a03-45a3-8d74-5aeb67631be4Product name120230831
85fc66a9-58b2-e194-7cdb-89ff44dcf3e6Product name420210518
9f9a82fd-fcee-442f-9233-7f2d2f9f4568Product name120180108

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82449-231-01FOCINVEZ1 in 1 CARTONINJECTION15
82449-231-01FOCINVEZ50 mL in 1 VIAL, SINGLE-DOSEINJECTION505

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82449-231FOCINVEZ (FOSAPREPITANT DIMEGLUMINE) INJECTION [STERISCIENCE SPECIALTIES PRIVATE LIMITED]2Current NDC, 2 package rows20241205_18a60093-cec8-1b8c-e063-6394a90a8902.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2664071FOCINVEZ 150 MG in 50 ML InjectionPSN18a60093-cec8-1b8c-e063-6394a90a89025
2664065fosaprepitant 150 MG in 50 ML InjectionPSN18a60093-cec8-1b8c-e063-6394a90a89025
266407150 ML fosaprepitant 3 MG/ML Injection [Focinvez]SBD18a60093-cec8-1b8c-e063-6394a90a89025
266406550 ML fosaprepitant 3 MG/ML InjectionSCD18a60093-cec8-1b8c-e063-6394a90a89025
266407150 ML Focinvez 3 MG/ML InjectionSY18a60093-cec8-1b8c-e063-6394a90a89025
2664071Focinvez 150 MG per 50 ML InjectionSY18a60093-cec8-1b8c-e063-6394a90a89025
2664065fosaprepitant 150 MG per 50 ML InjectionSY18a60093-cec8-1b8c-e063-6394a90a89025

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
82449-231-01824490231011 VIAL, SINGLE-DOSE in 1 CARTON (82449-231-01) / 50 mL in 1 VIAL, SINGLE-DOSE2024-06-26NoNoCurrent